China National Pharmaceutical Group (Sinopharm)

China National Pharmaceutical Group, commonly known as Sinopharm, is a major state-owned enterprise in China focused on pharmaceuticals and healthcare. It engages in the research, development, production, and distribution of medicines and medical equipment. Sinopharm is also notable for its role in vaccine development, particularly during the COVID-19 pandemic, where it produced and distributed vaccines both domestically and internationally. The company aims to improve public health and make healthcare accessible, playing a significant role in China’s healthcare system and global health initiatives.